Tempus Wealth Planning, LLC Pds Biotechnology Corp Transaction History
Tempus Wealth Planning, LLC
- $360 Million
- Q2 2025
A detailed history of Tempus Wealth Planning, LLC transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Tempus Wealth Planning, LLC holds 47,800 shares of PDSB stock, worth $48,278. This represents 0.02% of its overall portfolio holdings.
Number of Shares
47,800
Previous 18,800
154.26%
Holding current value
$48,278
Previous $22,000
186.36%
% of portfolio
0.02%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding PDSB
# of Institutions
61Shares Held
7.44MCall Options Held
98.2KPut Options Held
0-
Armistice Capital, LLC New York, NY2.24MShares$2.26 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$1.97 Million0.0% of portfolio
-
Ubs Group Ag543KShares$548,4510.0% of portfolio
-
Black Rock Inc. New York, NY487KShares$491,8360.0% of portfolio
-
Geode Capital Management, LLC Boston, MA418KShares$422,1130.0% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $28.7M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...